A detailed history of Emerald Mutual Fund Advisers Trust transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 419,462 shares of LBPH stock, worth $25 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
419,462
Previous 183,577 128.49%
Holding current value
$25 Million
Previous $4.96 Million 181.74%
% of portfolio
0.79%
Previous 0.28%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$27.58 - $39.5 $6.51 Million - $9.32 Million
235,885 Added 128.49%
419,462 $14 Million
Q2 2024

Aug 06, 2024

BUY
$17.0 - $27.03 $3.12 Million - $4.96 Million
183,577 New
183,577 $4.96 Million

Others Institutions Holding LBPH

About Longboard Pharmaceuticals, Inc.


  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $811M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.